Deferiprone in iron overload.
Mehta
J
J
Singhal
S
S
Mehta
B C
BC
D000974:Antibodies, Antinuclear / Q000032:analysis*; D001323:Autoantibodies / Q000032:analysis*; D002626:Chemistry, Pharmaceutical; D000077543:Deferiprone; D006657:Histones / Q000276:immunology; D006801:Humans; D007502:Iron Chelating Agents / Q000009:adverse effects* / Q000737:chemistry; D011728:Pyridones / Q000009:adverse effects* / Q000737:chemistry; D013789:Thalassemia / Q000188:drug therapy / Q000276:immunology*; D013997:Time Factors
D000974:Antibodies, Antinuclear; D001323:Autoantibodies; D006657:Histones; D007502:Iron Chelating Agents; D011728:Pyridones; D000077543:Deferiprone